| Literature DB >> 30704060 |
Camila Rodrigues1, Susan S Percival2.
Abstract
Glutathione and aged garlic extract are sulfur-containing products that play important protective and regulatory roles within the immune system and in oxidative processes. Hydrogen sulfide (H₂S), an endogenous, gaseous, signaling transmitter, has also been shown to be involved in the regulation of inflammation. Recent studies have shown that sulfur-containing compounds from garlic have beneficial effects in attenuating outcomes associated with cardiovascular disease and inflammation by a mechanism that may be related to the H₂S signaling pathway. In this review, we summarize the main functions of glutathione (GSH), garlic derivatives and H₂S and their role in the immune response and impact on health and disease.Entities:
Keywords: aged garlic extract; glutathione; hydrogen sulfide; immune response; inflammation
Mesh:
Substances:
Year: 2019 PMID: 30704060 PMCID: PMC6412746 DOI: 10.3390/nu11020295
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Summary of previous studies on the effect of glutathione in the immune response.
| Model | Treatment | Dose | Immune Response | Reference |
|---|---|---|---|---|
| Cell culture of isolated DC and T cells from study mice | Cysteine | -Redox modeling of Tregs through reduction of GSH synthesis in DC. | [ | |
| Cell culture of isolated leukocytes from healthy human blood | GSH-oxidizing agents (diamide and BHP) | 50 nmoL per 106 cells | -Regulation of phagocytosis in PMN through the inhibition of the assembly of microtubules and consequently reduction of H2O2 production in GSH homeostasis. | [ |
| Cell culture of isolated splenic naive T cells from mice | NAC in GSH depleted cells | 20 mM NAC per 106 cells in the presence of 1 mM BSO | -Inhibition of T cell proliferation and reduction IL-2 production in GSH depleted cells. | [ |
| Cell culture of isolated glomerular mesangial cell from rats | GSH | 3–5 mM GSH per 0.5–1 × 106 cells | -Inhibition of the complement activation cascade and the binding of antibodies to antigens. | [ |
| Human randomized controlled clinical trial in HIV-infected patients | NAC | ~7 g/day, oral | -Increase in GSH levels in the blood and in CD4 T cells. | [ |
| Human randomized controlled clinical trial in HIV-infected patients | Liposomal-GSH | 1.26 g/day, oral | -Increase in the levels of total GSH in CD4 T cells, IL-6, IL-12, IL-2, IFN-γ and reduction in the levels of IL-10. | [ |
| Patients with cirrhosis | GSH precursor (oxathizolidine-4-carboxylic acid) | 210 mg/kg/day, intravenous | -Reduction in the levels of IL-8 and IL-6 from isolated monocytes. | [ |
Abbreviations: DC (dendritic cells); GSH (glutathione); NAC (N-acetylcysteine); BSO (L-buthionine-sulfoximine); HIV (human immunodeficiency virus); IL (interleukin); IFN-γ (interferon-gamma).
Previous studies on the effect of garlic derivatives in the immune response.
| Model | Treatment | Dose | Immune response | Reference |
|---|---|---|---|---|
| Cell culture of isolated PBMC from healthy individuals | Fresh garlic extract | 0.5–4 μg/mL per 106 cells | -Decrease of IL-17 expression when stimulated with PHA. | [ |
| Cell culture of 3T3-L1 adipocytes | Alliin | 100 μmol/L (number of cells were not specified) | -Down-regulation of IL-6, MCP-1 genes expression and decrease of IL-6, MCP-1 protein levels. | [ |
| Cell culture of human colorectal cancer SW480 cells | DADS | 2.5–40 μmol/L (number of cells were not specified) | -Reduction of phosphorylation and nuclear translocation of NF-κB/p65 protein in a dose dependent way. | [ |
| Cell culture of isolated splenocytes from mice | AGE | 0.5-1 v/v% per 0.2–1 × 107 cells | -Increase in NK cell activation and cytotoxic T cells with suppression of tumor cell growth. | [ |
| Cell culture of Jurkat T cells | SAC | 0, 0.5, 1, 1.5, or 2 mg/mL of SAC in 106 cells | -Inhibition of NF-κB p50/65 heterodimer activation. | [ |
| Mice with leukemia | DATS | 1 and 10 mg/kg, oral | -Increase of phagocytosis activity on PBMC. | [ |
| Mice with implanted breast tumors | Purified protein fraction from garlic extract | 0.01–0.04 mg/mL, inoculation into the lesion | -Increase of T-cell activation and increase of intra-tumor infiltration of lymphocytes in all doses | [ |
| Mice with alcoholic fatty liver disease | Allicin | 5 mg/kg/day and 20 mg/kg/day, oral | -Reduction of TNF-α, IL-1β and IL-6 levels with 20 mg dose. | [ |
| Mice | Purified fraction of garlic extract | 10–40 mg/mL, oral | -Increase of NK activity with the 20 mg/mL dose. | [ |
| Mice with colitis | Alliin | 500 mg/kg, oral | -Suppression of LPS-induced AP-1/NF-κB/STAT-1 activation. | [ |
| Mice exposed to Aflatoxin B1 | AGE | 20 mg/kg/day, intraperitoneal | -Decrease in IFN-γ and IL-4 levels in isolated splenocytes. | [ |
| Mice with implanted fibrosarcoma tumor | AGE | 100 mg/kg (containing 0.4 g of garlic/mL), intraperitoneal | -Increase in spleen lymphocyte subpopulation ratio and IFN-γ levels. | [ |
| Rats with induced neuroinflammation | AGE | 125, 250, 500 mg/kg, oral | -Decrease in the density of CD11b-positive microglia immunoreactivity and decrease in up-regulation of IL-1β in hippocampal region at all doses. | [ |
| Mice with diabetes | SAC | 0.5 g/L, oral by drinking water | -Reduction in renal levels of IL-6 and TNF-α. | [ |
| Rats with diabetes | SAC | 150 mg/kg/day, oral | -Reduction in hippocampal NF-κB, TLR4 and TNF-α. | [ |
| Rats with chromium (VI)-induced hepatotoxicity | SAC | 100 mg/kg, oral | -Decrease in the expression of NF-κB, TNF-α and iNOS in the liver. | [ |
| Human randomized crossover study in healthy individuals | Raw crushed garlic | 5 g, oral | -Increase of | [ |
| Human randomized controlled clinical trial in patients with advanced colon, liver and pancreatic cancer | AGE | 500 mg/day, oral | -Increase in NK cell count and activity. | [ |
| Human randomized controlled clinical trial in healthy individuals | AGE | 2.56 g/day, oral | -Increase in γδ-T cells and NK cells. | [ |
| Human randomized controlled clinical trial in obese individuals | AGE | 3.6 g/day, oral | -Increase in γδ-T cell population and decrease in NKT cell population, IL-6 and TNF-α levels in the serum. | [ |
Abbreviations: PBMC (peripheral blood mononuclear cells); MCP-1 (monocyte chemoattractant protein 1); DADS (diallyl disulfide); NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells); NF-κB/p65 (nuclear factor kappa-light-chain-enhancer of activated B cells/p65 subunit); AGE (aged garlic extract); NK (natural killer); TNF-α (tumor necrosis factor-alpha); IFN-γ (interferon-gamma); SAC (S-allyl cysteine); DATS (diallyl trisulfide); LPS (lipopolysaccharide); AP-1 (activator protein 1); STAT-1 (signal transducer and activator of transcription 1); CD (clutter of differentiation); TLR (toll-like receptor); iNOS (inducible nitric oxide synthase).
Previous studies on the effect of hydrogen sulfide on inflammation.
| Model | Treatment | Dose | Immune response | Reference |
|---|---|---|---|---|
| Cell culture of RAW264.7 cells | FW1256 (H2S donor) | 200 μM per 2 × 105 or 106 cells | -Decrease in TNF-α, IL-6, PGE2, NO levels and expression of IL-1β, COX2, and iNOS. | [ |
| Cell culture of THP-1 cells | NaHS | 0.01, 0.1, 0.5 or 1 mM per 2 × 106 cells | -Decrease in IL-6 and TNF-α levels in a dose dependent manner. | [ |
| Cell culture of U937 cells | NaHS | 0.01, 0.1, or 1 mM (number of cells were not specified) | -Increase in mRNA expression and protein levels of TNF-α, IL-1β and IL-6 with 0.1 and 1mM doses. | [ |
| Cell culture of human fibroblast-like synoviocytes | NaHS | 0.05–5 mM (number of cells were not specified) | -Increase in mRNA expression of TNF-α, IL-8, IL-1α, IL-1β and COX-2 at 2 mM dose. | [ |
| Mice with colitis | ATB-429 (H2S donor) | 33–130 mg/kg, oral | -Reduction of mRNA expression of TNF-α, IFN-γ, IL-1, IL-2, IL-12 p40 and RANTES. | [ |
| Rats with colitis | NaHS and Lawesson’s reagent (H2S donors) | 30 μmol/kg, intracolonically | -Reduction of mRNA expression of TNF-α with both donors. | [ |
| Mice with LPS-induced airway inflammation | GYY4137 (H2S donor) and NaHS | GYY4137:0.3 or 1 mg/kg | -Prevention of neutrophil increase in bronchoalveolar lavage fluid with both donors. | [ |
| Rats with chronic renal failure | NaHS | 100 μmol/kg, intraperitoneal | -Decrease in TNF-α, IL-6, IL-10, and MCP-1 renal levels with both donors. | [ |
Abbreviations: COX2 (cyclooxygenase-2); iNOS (inducible nitric oxide synthase); RANTES (regulated on activation, normal T cell expressed and secreted); NaHS (sodium hydrosulfide).
Figure 1Schematic illustration of the proposed mechanism by which GSH, SAC and H2S affect the activation of the canonical NF-κB pathway. The canonical NF-κB pathway is the major pathway responsible for controlling inflammatory events through translocation of p50/p65 heterodimer to the nucleus. This event induces the production of pro-inflammatory cytokines and other chemochines, such as IL-6, TNF-α, IL-1β, MIP-1α, MPC-1 and COX-2 enzyme. It has been suggested that GSH has anti-inflammatory effects by reducing the levels of pro-inflammatory cytokines production. SAC, a constituent from AGE, has been shown to inhibit p50/p65 activation and the levels of pro-inflammatory cytokines. Contrarily, H2S seems to have both inhibitory and activating effects in the NF-κB pathway. Abbreviations: R (receptor); NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells); NEMO (NF-kB essential modulator); IκB (inhibitor of kappa B); IκBα (inhibitor of kappa B alpha); IKKα (IκB kinase alpha); IKKβ (IκB kinase beta); P (phosphorylation); Ub (ubiquitination); TNF-α (tumor necrosis factor-alpha); MIP-1 (macrophage inflammatory protein-1); MCP-1 (monocyte chemoattractant protein-1); COX2 (cyclooxygenase-2), SAC (S-allyl cysteine); GSH (glutathione), H2S (hydrogen sulfide).